TITLE

249 Heart-specific inhibition of transcription factor NFkappaB partially abrogates angiotensinII-induced hypertrophy in transgenic mice

AUTHOR(S)
Freund, C.; Pilz, B.; Schmidt-Ullrich, R.; Schneider, W.; Groß, V.; Dietz, R.; Scheidereit, C.; Bergmann, M.W.
PUB. DATE
June 2004
SOURCE
European Journal of Heart Failure. Supplements;Jun2004, Vol. 2 Issue 1, p50
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Heart-Specific Inhibition of Transcription Factor NFkappaB Partially Abrogates AngiotensinII-Induced Hypertrophy in Transgenic Mice," by C. Freund and colleagues is presented.
ACCESSION #
13022311

 

Related Articles

  • Compartimentalized NF-kappaB activity in the axon initial segment. König, Hans-Georg; Schwamborn, Robert; Politi, Chrisoula; Kögel, Donat; Deller, Thomas; Prehn, Jochen; Schultz, Christian // BMC Neuroscience;2007 Supplement 1, Vol. 8, pP10 

    An abstract of the paper "Compartimentalized NF-kappaB Activity in the Axon Initial Segment," by Robert Schwamborn and colleagues is presented.

  • Activation of NF-κB by nitric oxide/cGMP in human blood CD14+ cells. Siednienko, Jakub; Ciuman, Małgorzata; Witwicka, Hanna; Gorczyca, Wojciech A. // BMC Pharmacology;2005 Supplement 1, Vol. 5, p1 

    An abstract of the article "Activation of NF-ΚB by nitric oxide/cGMP in human blood CD14+ cells," by Jakub Siednienko, Hanna Witwicka and Wojciech A. Gorczyca is presented.

  • Angiotensin II protects fibroblast-like synoviocytes from apoptosis via the AT1-NF-{kappa}B pathway. L. Pattacini; B. Casali; L. Boiardi; N. Pipitone; L. Albertazzi; C. Salvarani // Rheumatology;Jul2007, Vol. 46 Issue 8, p1252 

    Objective. To evaluate the effects of angiotensin II (Ang II) treatment on apoptosis of fibroblast-like synoviocytes (FLS) from patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Methods. AT1 receptor expression was detected by western blotting and flow cytometry. Apoptosis...

  • Linking inflammation and hypertension in humans: studies in Bartter's/Gitelman's syndrome patients. Cal�, L. A.; Davis, P. A.; Pagnin, E.; Schiavo, S.; Semplicini, A.; Pessina, A. C. // Journal of Human Hypertension;Mar2008, Vol. 22 Issue 3, p223 

    The article examines the inflammation status through the evaluation of factors included in angiotensin II signaling involved in inflammation in Bartter's/Gitelman's syndrome patients. Results reveal unchanged phosphorylated extracellular signal-regulated kinase (pERK)/ERK ratio and p66shc...

  • Blockade of NF-?B ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II. Kawano, Shunichi; Kubota, Toru; Monden, Yoshiya; Kawamura, Natsumi; Tsutsui, Hiroyuki; Takeshita, Akira; Sunagawa, Kenji // Cardiovascular Research;Sep2005, Vol. 67 Issue 4, p689 

    Abstract: Objective: Nuclear factor (NF)-?B is a key transcription factor that regulates inflammatory processes. In the present study, we assessed the hypothesis that blockade of NF-?B may ameliorate ventricular hypertrophy in response to chronic infusion of angiotensin II. Methods: Mice with...

  • Endometriosis: basic research.  // Human Reproduction;Jul2007 Supplement 1, Vol. 22, pi186 

    The article presents abstracts on endometriosis, including the use of BAY11-7085, a nuclear factor-kappa B inhibitor, in treating endometriosis, the effects of ovarian hormones on early endometrial-peritoneal interaction in a mouse with endometriosis and the role of estradiol in estrogen...

  • 164 Nuclear factor-kappaB role at end stage heart failure in the hypertrophied myocardium. Salpeas, V.; Rizos, I.; Barberis, V.; Karamitros, I.; Cokkinos, D.; Toutouzas, P. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 2 Issue 1, p30 

    An abstract of the study "Nuclear factor-kappaB role at end stage heart failure in the hypertrophied myocardium," by V. Salpeas et al, is presented.

  • 689 The activation of the NF-kappaB system in chronic heart failure. Jankowska, E.A.; Czarny, A.; Zaczynska, E.; Banasiak, W.; Anker, S.; Ponikowski, P. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 2 Issue 1, p141 

    An abstract of the study "The Activation of the NF-kappaB System in Chronic Heart Failure," by E. A. Jankowska and colleagues is presented.

  • 693 A new NF-kB inhibitor suppressed production of cytokines and nitric oxide, and protected against heart failure due to viral myocarditis. Matsumori, A.; Nunokawa, Y.; Yamaki, A. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 2 Issue 1, p143 

    An abstract of the study "A New NF-kB Inhibitor Suppressed Production of Cytokines and Nitric Oxide, and Protected Against Heart Failure Due to Viral Myocarditis," by A. Matsumori and colleagues is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics